製品の概要

  • 製品名Anti-LAMC2 antibody
    LAMC2 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to LAMC2
  • アプリケーション適用あり: WBmore details
  • 種交差性
    交差種: Mouse
    交差が予測される動物種: Human
  • 免疫原

    Synthetic peptide conjugated to KLH, corresponding to a region within internal sequence amino acids 940-970 of Human LAMC2 (NP_005553.2, NP_061486.2).

  • ポジティブ・コントロール
    • Mouse stomach tissue lysate.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
  • バッファーPreservative: 0.09% Sodium azide
    Constituent: 99% PBS
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • 特記事項(精製)ab116660 was purified through a protein A column, followed by peptide affinity purification.
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab116660 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/100 - 1/500. Predicted molecular weight: 131 kDa.

ターゲット情報

  • 機能Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Ladsin exerts cell-scattering activity toward a wide variety of cells, including epithelial, endothelial, and fibroblastic cells.
  • 組織特異性The large variant is expressed only in specific epithelial cells of embryonic and neonatal tissues. In 17-week old embryo the small variant is found in cerebral cortex, lung, and distal tubes of kidney, but not in epithelia except for distal tubuli.
  • 関連疾患Defects in LAMC2 are a cause of epidermolysis bullosa junctional Herlitz type (H-JEB) [MIM:226700]; also known as junctional epidermolysis bullosa Herlitz-Pearson type. JEB defines a group of blistering skin diseases characterized by tissue separation which occurs within the dermo-epidermal basement membrane. H-JEB is a severe, infantile and lethal form. Death occurs usually within the first six months of life. Occasionally, children survive to teens. H-JEB is marked by bullous lesions at birth and extensive denudation of skin and mucous membranes that may be hemorrhagic.
  • 配列類似性Contains 8 laminin EGF-like domains.
    Contains 1 laminin IV type A domain.
  • ドメインThe alpha-helical domains I and II are thought to interact with other laminin chains to form a coiled coil structure.
    Domain IV is globular.
  • 細胞内局在Secreted > extracellular space > extracellular matrix > basement membrane. Major component.
  • Information by UniProt
  • 参照データベース
  • 別名
    • 3918 antibody
    • B2T antibody
    • BM600 antibody
    • Cell-scattering factor 140 kDa subunit antibody
    • CSF 140 kDa subunit antibody
    • CSF antibody
    • EBR2 antibody
    • EBR2A antibody
    • Epiligrin subunit gamma antibody
    • Kalinin subunit gamma antibody
    • Kalinin/nicein/epiligrin 100 kDa subunit antibody
    • Ladsin 140 kDa subunit antibody
    • LAMB2T antibody
    • LAMC2 antibody
    • LAMC2_HUMAN antibody
    • Laminin 5 gamma 2 subunit antibody
    • Laminin B2t chain antibody
    • Laminin gamma 2 antibody
    • laminin gamma 2 chain antibody
    • Laminin subunit gamma-2 antibody
    • Laminin-5 subunit gamma antibody
    • LAMNB2 antibody
    • Large adhesive scatter factor 140 kDa subunit antibody
    • MGC138491 antibody
    • MGC141938 antibody
    • Nicein subunit gamma antibody
    • NICEIN-100KDA antibody
    see all

Anti-LAMC2 antibody 画像

  • Anti-LAMC2 antibody (ab116660) at 1/100 dilution + Mouse stomach tissue lysate at 35 µg

    Predicted band size : 131 kDa

Anti-LAMC2 antibody (ab116660) 使用論文

ab116660 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab116660.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"